Clinical Trial Update: Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Yonsei University evaluating enavogliflozin for preventing recurrence of atrial fibrillation after catheter ablation; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Yonsei University | Conditions: Atrial Fibrillation | Phase 4 | Status: NOT_YET_RECRUITING